Breast cancer survivor shares story of hope and healing
Published . Updated .
Breast cancer survivor shares story of hope and healing KBTX News 3
Directly affected
- No company is named in this report.
Indirectly affected
- NAMS NEW AMSTERDAM PHARMA CO ORDINARY SHARES
GA selected NAMS as a RELATED security because its canonical security name directly matches this event's themes: pharma, shares. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BBIO BRIDGEBIO PHARMA INC
GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- CRDF CARDIFF ONCOLOGY INC COM
GA selected CRDF as a RELATED security because its canonical security name directly matches this event's themes: oncology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Breast cancer survivor shares story of hope and healing KBTX News 3
Source: KBTX News 3
NewAmsterdam Pharma Co N.V (NAMS)
Across 4 earlier stories, NewAmsterdam Pharma Co N.V (NAMS) the next day averaged -2.01%. The largest gain was +1.90% and the largest drop was -5.93%, from 2 prices.
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| NewAmsterdam Pharma Co N.V (NAMS) | the next day | -2.01% | +1.90% | -5.93% | 2 |
| NewAmsterdam Pharma Co N.V (NAMS) | three days later | -2.71% | +1.29% | -6.70% | 2 |
| Acadia Healthcare (ACHC) | the next day | +3.99% | +5.29% | +2.68% | 4 |
| Acadia Healthcare (ACHC) | three days later | -0.23% | -0.13% | -0.33% | 4 |
| Ascendis Pharma A/S (ASND) | the next day | +0.77% | +1.50% | +0.04% | 4 |
| Ascendis Pharma A/S (ASND) | three days later | +1.15% | +3.06% | -0.76% | 4 |
| aTYR PHARMA (ATYR) | the next day | -11.77% | -7.30% | -16.23% | 4 |
| aTYR PHARMA (ATYR) | three days later | -16.38% | -14.58% | -18.17% | 4 |
The price since 13 Oct 2026: NewAmsterdam Pharma Co N.V (NAMS) versus the S&P 500
Since the first closing price after “Breast cancer survivor shares story of hope and healing,” NewAmsterdam Pharma Co N.V (NAMS) is +2.37%. The S&P 500 fund (SPY) is -0.40% over the same days, a +2.77% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| Acadia Healthcare (ACHC) | that day | +4.76% | final price |
| Acadia Healthcare (ACHC) | the next day | +2.68% | final price |
| Acadia Healthcare (ACHC) | two days later | -0.83% | final price |
| Acadia Healthcare (ACHC) | three days later | -0.13% | final price |
| Acadia Healthcare (ACHC) | three days earlier | -3.24% | final price |
| Acadia Healthcare (ACHC) | five days earlier | -3.31% | final price |
| Ascendis Pharma A/S (ASND) | that day | +1.69% | final price |
| Ascendis Pharma A/S (ASND) | the next day | +1.50% | final price |
| Ascendis Pharma A/S (ASND) | two days later | +0.88% | final price |
| Ascendis Pharma A/S (ASND) | three days later | +3.06% | final price |
| Ascendis Pharma A/S (ASND) | three days earlier | +2.69% | final price |
| Ascendis Pharma A/S (ASND) | five days earlier | +2.24% | final price |
| aTYR PHARMA (ATYR) | that day | -9.15% | final price |
| aTYR PHARMA (ATYR) | the next day | -7.30% | final price |
| aTYR PHARMA (ATYR) | two days later | -11.25% | final price |
| aTYR PHARMA (ATYR) | three days later | -14.58% | final price |
| aTYR PHARMA (ATYR) | three days earlier | +23.90% | final price |
| aTYR PHARMA (ATYR) | five days earlier | +38.85% | final price |
| BridgeBio Pharma (BBIO) | that day | +2.59% | final price |
| BridgeBio Pharma (BBIO) | the next day | +6.05% | final price |
| BridgeBio Pharma (BBIO) | two days later | +4.88% | final price |
| BridgeBio Pharma (BBIO) | three days later | +7.33% | final price |
| BridgeBio Pharma (BBIO) | three days earlier | +3.24% | final price |
| BridgeBio Pharma (BBIO) | five days earlier | +5.06% | final price |
| Cardiff Oncology (CRDF) | that day | -3.96% | final price |
| Cardiff Oncology (CRDF) | the next day | -3.96% | final price |
| Cardiff Oncology (CRDF) | two days later | -10.89% | final price |
| Cardiff Oncology (CRDF) | three days later | -12.31% | final price |
| Cardiff Oncology (CRDF) | three days earlier | +6.93% | final price |
| Cardiff Oncology (CRDF) | five days earlier | +7.92% | final price |
Disclosure records for NewAmsterdam Pharma Co N.V (NAMS) within two months of 13 Oct 2026
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “Breast cancer survivor shares story of hope and healing”
Companies tied to this story
- NAMS NewAmsterdam Pharma Co N.V
NewAmsterdam Pharma Co N.V (NAMS) is linked, with no stored direction, medium confidence in the 13 Oct 2026 story “Breast cancer survivor shares story of hope and healing.” Reason on file: GA selected NAMS as a RELATED security because its canonical security name directly matches this event's themes: pharma, shares. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ACHC Acadia Healthcare
In “Breast cancer survivor shares story of hope and healing,” Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
In “Breast cancer survivor shares story of hope and healing,” Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence. Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
In “Breast cancer survivor shares story of hope and healing,” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
For “Breast cancer survivor shares story of hope and healing,” BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CRDF Cardiff Oncology
Cardiff Oncology (CRDF) is linked, with no stored direction, medium confidence in the 13 Oct 2026 story “Breast cancer survivor shares story of hope and healing.” Reason on file: GA selected CRDF as a RELATED security because its canonical security name directly matches this event's themes: oncology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “Breast cancer survivor shares story of hope and healing” reaches NewAmsterdam Pharma Co N.V (NAMS)
On 13 Oct 2026, “Breast cancer survivor shares story of hope and healing” is the story that connects NewAmsterdam Pharma Co N.V (NAMS) to this story.
NewAmsterdam Pharma Co N.V (NAMS) is on the page because GA selected NAMS as a RELATED security because its canonical security name directly matches this event's themes: pharma, shares. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Also listed, Acadia Healthcare (ACHC): GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for NewAmsterdam Pharma Co N.V (NAMS), and the dates in the story
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. NAMS traded between 19.58 and 25.10 across 20 sessions. The latest close on file is 20.49.
How strong the case is around NewAmsterdam Pharma Co N.V (NAMS)
46 out of 100
“Breast cancer survivor shares story of hope and healing” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.